These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2731987)

  • 1. Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice.
    Murray PJ; Spithill TW; Handman E
    Infect Immun; 1989 Jul; 57(7):2203-9. PubMed ID: 2731987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice.
    Handman E; Button LL; McMaster RW
    Exp Parasitol; 1990 May; 70(4):427-35. PubMed ID: 2182337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous protection in murine cutaneous leishmaniasis.
    Mitchell GF; Handman E
    Immunol Cell Biol; 1987 Oct; 65 Pt 5():387-92. PubMed ID: 3436638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen.
    Murray PJ; Spithill TW; Handman E
    J Immunol; 1989 Dec; 143(12):4221-6. PubMed ID: 2592773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.
    Garg R; Srivastava JK; Pal A; Naik S; Dube A
    Vaccine; 2005 Jan; 23(9):1189-96. PubMed ID: 15629362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.
    Kahl LP; Lelchuk R; Scott CA; Beesley J
    Infect Immun; 1990 Oct; 58(10):3233-41. PubMed ID: 2401562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterogeneity of Leishmania cell-surface antigens.
    Hernández AG; Payares G; Misle A; Dagger F
    Parasitol Res; 1989; 75(8):583-8. PubMed ID: 2771925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subspecies-specific surface antigens of promastigotes of the Leishmania donovani complex.
    Lemesre JL; Rizvi FS; Afchain D; Sadigursky M; Capron A; Santoro F
    Infect Immun; 1985 Oct; 50(1):136-41. PubMed ID: 3899930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An immunologic method of producing antigens for the treatment and prevention of leishmaniasis].
    Vouldoukis I; Monjour L
    C R Acad Sci III; 1989; 308(5):129-34. PubMed ID: 2493318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytoplasmic soluble antigens related to the major surface antigens of Leishmania braziliensis braziliensis and L. donovani chagasi.
    Kutner S; Pellerin P; Breniere SF
    Parasitol Res; 1990; 76(3):185-91. PubMed ID: 2179945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the major surface proteins of three Leishmania species are structurally related.
    Etges RJ; Bouvier J; Hoffman R; Bordier C
    Mol Biochem Parasitol; 1985 Feb; 14(2):141-9. PubMed ID: 3990704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and partial purification of a cell surface component of Leishmania braziliensis.
    Misle JA; Márquez ME; Hernández AG
    Z Parasitenkd; 1985; 71(4):419-28. PubMed ID: 4024707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses.
    Burns JM; Scott JM; Carvalho EM; Russo DM; March CJ; Van Ness KP; Reed SG
    J Immunol; 1991 Jan; 146(2):742-8. PubMed ID: 1824776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophosphoglycan and secreted acid phosphatase of Leishmania tropica share species-specific epitopes.
    Jaffe CL; Perez L; Schnur LF
    Mol Biochem Parasitol; 1990 Jun; 41(2):233-40. PubMed ID: 1697935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114.
    Radolf JD; Norgard MV
    Infect Immun; 1988 Jul; 56(7):1825-8. PubMed ID: 3290110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis.
    Jaffe CL; Zalis M
    Mol Biochem Parasitol; 1988 Jan; 27(1):53-62. PubMed ID: 3343999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.